文献速递关节外科创伤骨科

多剂量静脉氨甲环酸进一步减少全髋关节置换术后隐性失血:一项随机对照试验

Multiple-Dose Intravenous Tranexamic Acid Further Reduces Hidden Blood Loss After Total Hip Arthroplasty: A Randomized Controlled Trial.
PubMed 文献 · J Arthroplasty · 2018-04-23

150例全髋关节置换术患者随机分为A组(切皮前1剂+术后2剂)、B组(3剂)、C组(4剂),每3小时给药一次。主要结局隐性失血在C组显著低于B组和A组,B组也显著低于A组;C组术后最低血红蛋白更高,D-二聚体和白细胞介素-6在术后24和48小时显著更低;三组住院时间无显著差异,无输血及深静脉血栓或肺栓塞发生。

要点

  • 多剂量静脉氨甲环酸呈剂量依赖性减少全髋关节置换术后隐性失血。
  • C组(4剂)术后最低血红蛋白显著高于B组和A组,B组也显著高于A组。
  • 三组住院时间无显著差异,无患者输血,无深静脉血栓或肺栓塞发生。

核心结论

  • 5剂静脉氨甲环酸方案可进一步减少全髋关节置换术后隐性失血、降低最大血红蛋白下降、提供额外纤溶控制并改善术后炎症反应。

研究设计与样本

  • 随机对照试验,纳入150例全髋关节置换术患者,随机分为A组(切皮前1剂+术后2剂)、B组(3剂)、C组(4剂),每3小时给药一次。

主要发现

  • C组平均隐性失血、总失血量及最大血红蛋白下降均显著低于B组和A组,B组也显著低于A组。
  • C组术后最低血红蛋白显著高于B组和A组,B组也显著高于A组。
  • C组术后24和48小时D-二聚体和白细胞介素-6显著低于B组和A组,B组也显著低于A组。
  • 三组住院时间无显著差异,住院期间无患者输血,所有病例无深静脉血栓或肺栓塞发生。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The most appropriate dose of tranexamic acid in total hip arthroplasty (THA) has not been decided. This study was conducted to evaluate the clinical effects of multiple-dose intravenous tranexamic acid (IV-TXA) in THA. METHODS: One hundred fifty patients were randomized to receive one dose of IV-TXA before incision, followed by 2 doses of IV-TXA (group A), or 3 doses of IV-TXA (group B), or 4 doses of IV-TXA (group C) at 3-hour intervals. The primary outcome was hidden blood loss (HBL). Other outcome measurements such as total blood loss, maximum hemoglobin (Hb) drop, postoperative lowest Hb level, fibrinolysis parameter (D-dimer), inflammatory factor (interleukin-6), transfusion rate, length of stay, and complications were also compared. RESULTS: The mean HBL, total blood loss, and maximum Hb drop were significantly lower in group C than in groups B and A. Such differences were also detected between groups B and A. The postoperative lowest Hb level was significantly higher in group C. D-dimer and interleukin-6 in group C were significantly lower than in groups B and A at 24 and 48 hours postoperatively. Such differences were also significant between groups B and A. There was no significant difference in length of stay among groups. No patient underwent blood transfusion during hospitalization. No episodes of deep venous thrombosis or pulmonary embolism occurred in all cases. CONCLUSION: The 5-dose IV-TXA regimen can further diminish HBL, decrease maximum Hb drop, provide additional fibrinolysis control, and ameliorate postoperative inflammatory response following THA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lei Y, Huang Q, Huang Z, et al. Multiple-Dose Intravenous Tranexamic Acid Further Reduces Hidden Blood Loss After Total Hip Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2018. PMID: 29759857. doi:10.1016/j.arth.2018.04.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。